Grant Harrow Health, Inc. Transaction History
Grant
- $192 Million
- Q2 2024
A detailed history of Grant transactions in Harrow Health, Inc. stock. As of the latest transaction made, Grant holds 41,602 shares of HROW stock, worth $1.58 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
41,602
Previous 41,502
0.24%
Holding current value
$1.58 Million
Previous $549,000
58.29%
% of portfolio
0.45%
Previous 0.29%
Shares
2 transactions
Others Institutions Holding HROW
# of Institutions
122Shares Held
19.7MCall Options Held
700KPut Options Held
575K-
Opaleye Management Inc. Boston, MA3.99MShares$152 Million21.35% of portfolio
-
Private Capital Management, LLC Naples, FL2.71MShares$103 Million7.1% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$81.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.84MShares$69.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA719KShares$27.3 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1.03B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...